Proposed Data Collection Submitted for Public Comment and Recommendations, 25057-25059 [2019-11220]
Download as PDF
<![CDATA[
25057
Federal Register / Vol. 84, No. 104 / Thursday, May 30, 2019 / Notices
survival. These data are used to measure
the changing incidence and burden of
each cancer; identify populations at
increased or increasing risk; target
preventive measures; and measure the
success or failure of cancer control
efforts in the U.S.
In 1992, Congress passed the Cancer
Registries Amendment Act which
established the National Program of
Cancer Registries (NPCR). The NPCR
provides support for state/territorybased cancer registries that collect,
manage and analyze data about cancer
cases. The state/territory-based cancer
registries report information to CDC
through the National Program of Cancer
Registries Cancer Surveillance System
(NPCR CSS), (OMB Control No. 0920–
0469). CDC plans to request OMB
approval to continue collecting this
information for three years. Data
definitions will be updated to reflect
changes in national standards for cancer
diagnosis and coding. The number of
respondents has been updated to reflect
the increased number of states/
territories supported by CDC, but the
burden per respondent will not change.
The NPCR CSS allows CDC to collect,
aggregate, evaluate, and disseminate
The first NPCR CSS Standard file,
submitted in January, is a preliminary
report consisting of one year of data for
the most recent year of available data.
CDC evaluates the preliminary data for
completeness and quality and provides
a report back to the CCR. The second
NPCR CSS Standard file, submitted by
November, contains cumulative cancer
incidence data from the first diagnosis
year for which the cancer registry
collected data with the assistance of
NPCR funds (e.g., 1995) through 12
months past the close of the most recent
diagnosis year (e.g., 2016). The
cumulative file is used for analysis and
reporting.
The burden for each file transmission
is estimated at two hours per response.
Because cancer incidence data are
already collected and aggregated at the
state level the additional burden of
reporting the information to CDC is
small. All information is transmitted to
CDC electronically. Participation is
required as a condition of the
cooperative agreement with CDC. The
total estimated annual burden hours is
200. There are no costs to respondents
except their time.
cancer incidence data at the national
level. The NPCR CSS is the primary
source of information for United States
Cancer Statistics (USCS), which CDC
has published annually since 2002. The
latest USCS report published in 2018
provided cancer statistics for 100% of
the United States population from all
cancer registries in the United States.
Prior to the publication of USCS, cancer
incidence data at the national level were
available for only 14% of the population
of the United States.
The NPCR CSS also allows CDC to
monitor cancer trends over time,
describe geographic variation in cancer
incidence throughout the country, and
provide incidence data on racial/ethnic
populations and rare cancers. These
activities and analyses further support
CDC’s planning and evaluation efforts
for state and national cancer control and
prevention. In addition, datasets can be
made available for secondary analysis.
Respondents are NPCR-supported
central cancer registries (CCR) in 46 U.S.
states, three territories, and the District
of Columbia. Fifty CCRs submit data
elements specified for the Standard
NPCR CSS Report. Each CCR is asked to
transmit two data files to CDC per year.
ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden
per response
(in hours)
Number of
responses per
respondent
Total burden
(in hours)
Form name
Central Cancer Registries in States,
Territories, and the District of Columbia.
Standard NPCR CSS Report ...........
50
2
2
200
Total ...........................................
...........................................................
........................
........................
........................
200
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2019–11216 Filed 5–29–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–19–19AWX; Docket No. CDC–2019–
0042]
jbell on DSK3GLQ082PROD with NOTICES
Number of
respondents
Type of respondents
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
VerDate Sep<11>2014
18:08 May 29, 2019
Jkt 247001
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled WISEWOMAN National Program
Evaluation. The goal of the study is to
assess the implementation of the
WISEWOMAN program under the
current cooperative agreement and
measure the effect of the program on
individual-, organizational-, and
community-level outcomes.
SUMMARY:
CDC must receive written
comments on or before July 29, 2019.
DATES:
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
You may submit comments,
identified by Docket No. CDC–2019–
0042 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
ADDRESSES:
Please note: Submit all comments through
the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
To
request more information on the
proposed project or to obtain a copy of
FOR FURTHER INFORMATION CONTACT:
E:\FR\FM\30MYN1.SGM
30MYN1
25058
Federal Register / Vol. 84, No. 104 / Thursday, May 30, 2019 / Notices
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
retained (e.g., provision of screening
services, promotion of healthy lifestyle
behaviors, and linkage to healthy
behavior support services and
community based resources), but a
number of changes were incorporated
into the program at that time. The
current FOA reflects increased emphasis
on three strategies to reduce CVD risk
and support hypertension control and
management, including: (1) Tracking
and monitoring clinical measures, (2)
implementing team-based care, and (3)
linking community resources and
clinical services to support care
coordination, self-management, and
lifestyle change.
CDC seeks to conduct a one-time,
multi-component evaluation to assess
the effectiveness of the program on
individual-, organizational-, and
community-level outcomes. The indepth assessment is designed to
complement the routine progress and
MDE information already being
collected from WISEWOMAN program
recipients. The new data collection will
focus on obtaining qualitative and
quantitative information at the
organizational and community levels
about process and procedures
implemented, and barriers, facilitators,
and other contextual factors that affect
program implementation and
participant outcomes. Data collection
activities will include a Program Survey
with all WISEWOMAN awardee
programs, administered in the second
and fourth program years, and a onetime site visit to each recipient spread
across the three-year data collection
effort. During site visits, semi-structured
interviews will be conducted with
WISEWOMAN staff members and staff
at partner organizations, such as clinical
providers and community-based
resource providers, who are positioned
to provide a variety of perspectives on
program implementation.
OMB approval is requested for three
years. Participation is voluntary and
there are no costs to respondents other
than their time.
Proposed Project
WISEWOMAN National Program
Evaluation—New—National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The CDC has supported the
WISEWOMAN (Well-Integrated
Screening and Evaluation for Women
Across the Nation) program since 1995.
The WISEWOMAN program is designed
to serve low-income women ages 40–64
who have elevated risk factors for
cardiovascular disease (CVD) and have
no health insurance, or are
underinsured for medical and
preventive care services. Through the
WISEWOMAN program, women have
access to screening services for selected
CVD risk factors such as elevated blood
cholesterol, hypertension, and abnormal
blood glucose levels; referrals to heathy
behavior support programs; and
referrals to medical care. WISEWOMAN
participants must be co-enrolled in the
CDC-sponsored National Breast and
Cervical Cancer Early Detection Program
(NBCCEDP).
The WISEWOMAN program is
administered through cooperative
agreements with state, territorial, or
tribal health departments. Each
WISEWOMAN recipient submits to CDC
an annual progress report that describes
program objectives and activities, and
semi-annual data reports (known as
minimum data elements, or MDE) on
the screening, assessment, and healthy
behavior support services offered to
women who participate in the program.
Participant-level MDE are de-identified
prior to transmission to CDC.
In 2018, CDC released the fifth
funding opportunity announcement
(FOA) for the WISEWOMAN program
(DP18–1816), which resulted in fiveyear cooperative agreements with 24
state, territorial, and tribal health
departments, including 6 new and 18
continuing awardees from the previous
NOFO. Key program elements were
jbell on DSK3GLQ082PROD with NOTICES
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Number of
respondents
Average
burden per
response
(in hours)
Total burden
(in hours)
Type of respondents
Form name
WISEWOMAN Recipient Administrators.
Program survey ................................
18
1
1
16
Site Visit Discussion Guide ..............
Innovation Site Visit Discussion
Guide.
Site Visit Discussion Guide ..............
Innovation Site Visit Discussion
Guide.
8
2
1
1
90/60
45/60
12
2
16
2
1
1
1
45/60
16
2
Recipient partners .............................
VerDate Sep<11>2014
18:08 May 29, 2019
Jkt 247001
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
E:\FR\FM\30MYN1.SGM
30MYN1
25059
Federal Register / Vol. 84, No. 104 / Thursday, May 30, 2019 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Average
burden per
response
(in hours)
Number of
responses per
respondent
Total burden
(in hours)
Form name
Healthy behavior support staff ..........
Site Visit Discussion Guide ..............
Innovation Site Visit Discussion
Guide.
Site Visit Discussion Guide ..............
Innovation Site Visit Discussion
Guide.
16
2
1
1
1
45/60
16
2
16
2
1
1
1
45/60
16
2
...........................................................
........................
........................
........................
84
Clinical providers ...............................
Total ...........................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2019–11220 Filed 5–29–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10701]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
July 29, 2019.
SUMMARY:
jbell on DSK3GLQ082PROD with NOTICES
Number of
respondents
Type of respondents
VerDate Sep<11>2014
18:08 May 29, 2019
Jkt 247001
When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number ____, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ website address at
https://www.cms.gov/Regulations-andGuidance/Legislation/Paperwork
ReductionActof1995/PRA-Listing.html.
2. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
ADDRESSES:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–10701 Medicare Beneficiary
Experiences With Care Survey System
(MBECS).
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collection
1. Type of Information Collection
Request: New collection (Request for a
new OMB control number); Title of
Information Collection: Medicare
Beneficiary Experiences with Care
Survey System; Use: The MBECS system
is designed to conduct 1–2 surveys per
year on priority groups of interest,
thereby allowing CMS OMH to respond
quickly to the data needs of
stakeholders with interests in these
underrepresented groups. Data collected
through the MBECS system will be used
to better understand—and thus serve the
needs of—Medicare beneficiaries in
minority populations. The core
questionnaire will collect information
on communication with medical
professionals, coordination of health
care, experiences getting needed health
care, experiences with personal doctors
and specialists, and key demographics.
Data will be compared to benchmarks
from the FFS CAHPS, MA CAHPS, and
NAM CAHPS surveys. The populationspecific questionnaire module will
collect information about issues most
relevant for particular minority groups;
population-specific modules will be
E:\FR\FM\30MYN1.SGM
30MYN1
]]>Agencies
[Federal Register Volume 84, Number 104 (Thursday, May 30, 2019)]
[Notices]
[Pages 25057-25059]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-11220]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-19-19AWX; Docket No. CDC-2019-0042]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled WISEWOMAN National Program
Evaluation. The goal of the study is to assess the implementation of
the WISEWOMAN program under the current cooperative agreement and
measure the effect of the program on individual-, organizational-, and
community-level outcomes.
DATES: CDC must receive written comments on or before July 29, 2019.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2019-
0042 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal
eRulemaking portal (regulations.gov) or by U.S. mail to the address
listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of
[[Page 25058]]
the information collection plan and instruments, contact Jeffrey M.
Zirger, Information Collection Review Office, Centers for Disease
Control and Prevention, 1600 Clifton Road NE, MS-D74, Atlanta, Georgia
30329; phone: 404-639-7570; Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
WISEWOMAN National Program Evaluation--New--National Center for
Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The CDC has supported the WISEWOMAN (Well-Integrated Screening and
Evaluation for Women Across the Nation) program since 1995. The
WISEWOMAN program is designed to serve low-income women ages 40-64 who
have elevated risk factors for cardiovascular disease (CVD) and have no
health insurance, or are underinsured for medical and preventive care
services. Through the WISEWOMAN program, women have access to screening
services for selected CVD risk factors such as elevated blood
cholesterol, hypertension, and abnormal blood glucose levels; referrals
to heathy behavior support programs; and referrals to medical care.
WISEWOMAN participants must be co-enrolled in the CDC-sponsored
National Breast and Cervical Cancer Early Detection Program (NBCCEDP).
The WISEWOMAN program is administered through cooperative
agreements with state, territorial, or tribal health departments. Each
WISEWOMAN recipient submits to CDC an annual progress report that
describes program objectives and activities, and semi-annual data
reports (known as minimum data elements, or MDE) on the screening,
assessment, and healthy behavior support services offered to women who
participate in the program. Participant-level MDE are de-identified
prior to transmission to CDC.
In 2018, CDC released the fifth funding opportunity announcement
(FOA) for the WISEWOMAN program (DP18-1816), which resulted in five-
year cooperative agreements with 24 state, territorial, and tribal
health departments, including 6 new and 18 continuing awardees from the
previous NOFO. Key program elements were retained (e.g., provision of
screening services, promotion of healthy lifestyle behaviors, and
linkage to healthy behavior support services and community based
resources), but a number of changes were incorporated into the program
at that time. The current FOA reflects increased emphasis on three
strategies to reduce CVD risk and support hypertension control and
management, including: (1) Tracking and monitoring clinical measures,
(2) implementing team-based care, and (3) linking community resources
and clinical services to support care coordination, self-management,
and lifestyle change.
CDC seeks to conduct a one-time, multi-component evaluation to
assess the effectiveness of the program on individual-, organizational-
, and community-level outcomes. The in-depth assessment is designed to
complement the routine progress and MDE information already being
collected from WISEWOMAN program recipients. The new data collection
will focus on obtaining qualitative and quantitative information at the
organizational and community levels about process and procedures
implemented, and barriers, facilitators, and other contextual factors
that affect program implementation and participant outcomes. Data
collection activities will include a Program Survey with all WISEWOMAN
awardee programs, administered in the second and fourth program years,
and a one-time site visit to each recipient spread across the three-
year data collection effort. During site visits, semi-structured
interviews will be conducted with WISEWOMAN staff members and staff at
partner organizations, such as clinical providers and community-based
resource providers, who are positioned to provide a variety of
perspectives on program implementation.
OMB approval is requested for three years. Participation is
voluntary and there are no costs to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
WISEWOMAN Recipient Program survey.. 18 1 1 16
Administrators.
Site Visit 8 1 90/60 12
Discussion
Guide.
Innovation Site 2 1 45/60 2
Visit
Discussion
Guide.
Recipient partners............ Site Visit 16 1 1 16
Discussion
Guide.
Innovation Site 2 1 45/60 2
Visit
Discussion
Guide.
[[Page 25059]]
Healthy behavior support staff Site Visit 16 1 1 16
Discussion
Guide.
Innovation Site 2 1 45/60 2
Visit
Discussion
Guide.
Clinical providers............ Site Visit 16 1 1 16
Discussion
Guide.
Innovation Site 2 1 45/60 2
Visit
Discussion
Guide.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 84
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019-11220 Filed 5-29-19; 8:45 am]
BILLING CODE 4163-18-P
